Breakthrough technology for all stages of disease.
SCINTIX® therapy from RefleXion may expand treatment options for hundreds of thousands of metastatic patients with tumors in the lung or bone, previously not eligible for radiotherapy. Learn more about eligible patients in your area.
SCINTIX technology automates targeting and motion management, two of the longest standing barriers preventing radiotherapy for metastatic disease and expanding treatment options for patients with tumors in the lung or bone.
DUAL-TREATMENT MODALITY PLATFORM
ONE MACHINE. MULTIPLE TREATMENTS.
The RefleXion® X1 platform is designed to deliver SCINTIX therapy and industry-leading CT-guided IMRT and SBRT to optimize practice workflow. Equipped with fan-beam kVCT imaging, the X1 provides superior imaging for patient localization resulting in improved confidence for accurate dose delivery.
Fits within your department’s existing footprint.
RefleXion doesn’t just fit within your practice clinically, but physically too. Our platform is designed to fit in your existing LINAC vault with minimum shielding requirements to reduce implementation and startup costs.